This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2022.
Company Filing History:
1 out of 834,411 Years Active: 2022
Title: Innovations by Hyunhyo Suh in Hepatitis Diagnosis
Introduction
Hyunhyo Suh is a notable inventor based in Jinju, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of liver disease. His innovative work focuses on the early detection and monitoring of chronic hepatitis and liver fibrosis.
Latest Patents
Hyunhyo Suh holds a patent for a "Kit for tracking and diagnosing degree of progressive chronic hepatitis and liver fibrosis by measuring asialo (alpha)1-acid glycoprotein as hepatocellular injury marker and use thereof." This invention provides a rapid and easy method to test for initial liver disease. It specifically utilizes a monoclonal antibody for α1-acid glycoprotein, allowing for the diagnosis of progressive chronic hepatitis and liver fibrosis by measuring the concentration of asialo-α1-acid glycoprotein (AsAGP) in a sample. The kit is designed to determine the degree of liver disease from a blood sample, employing an immunochromatography strip that includes a conjugate that specifically binds to asialo α1-acid glycoprotein.
Career Highlights
Throughout his career, Hyunhyo Suh has focused on advancing medical technology and improving diagnostic methods. His work has the potential to significantly impact the early detection of liver diseases, which is crucial for effective treatment and management.
Collaborations
Hyunhyo Suh has collaborated with notable colleagues, including WangJo Cha and Mikyung Chung. Their combined expertise has contributed to the development of innovative diagnostic solutions in the medical field.
Conclusion
Hyunhyo Suh's contributions to the field of liver disease diagnostics exemplify the importance of innovation in medicine. His patented technology offers a promising approach to early detection and monitoring of chronic hepatitis and liver fibrosis.